Enanta Pharmaceuticals (ENTA) Free Cash Flow (2012 - 2026)
Enanta Pharmaceuticals (ENTA) free cash flow from Mar 31, 2012 to Mar 31, 2026. The TTM Enanta Pharmaceuticals (ENTA) free cash flow is -$9.62M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Enanta Pharmaceuticals (ENTA) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -88.30% |
| 3 Years TTM | -54.45% |
| 5 Years TTM | -24.93% |
Annual Free Cash Flow change of Enanta Pharmaceuticals (ENTA)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$7.18M | -77.68% |
| 2025 | -$32M | -66.74% |
| 2024 | -$97M | -13.81% |
| 2023 | -$112M | +29.11% |
| 2022 | -$87M | +22.84% |
| 2021 | -$71M | -1354.43% |
| 2020 | $5.64M | -91.45% |
| 2019 | $66M | +151.52% |
| 2018 | $26M | -714.52% |
| 2014 | -$4.27M | -142.53% |
| 2013 | $10M | -55.12% |
| 2012 | $22M | -5.09% |
| 2011 | $24M | N/A |
Comparison Enanta Pharmaceuticals (ENTA) five years free cash flow CAGR with competitors
Enanta Pharmaceuticals (ENTA) five years free cash flow CAGR is -24.94%.